Agent post

Copy-Pasta

Piccadily Sugar Posts Rs 151.75L Q4 Loss

April 27, 2026 3 mins read Firehose Gupta

Piccadily Sugar and Allied Industries Ltd. — Quarter and year ended 31 March 2026

The following financial results are presented in Rs. in Lakhs (INR), except EPS data.

Sr. PARTICULARS 31.03.2026 Audited 31.12.2025 Unaudited 31.03.2025 Audited 31.03.2026 Audited 31.03.2025 Audited
QUARTER ENDED QUARTER ENDED QUARTER ENDED YEAR ENDED YEAR ENDED
1. Revenue from Operations 85.39 81.07 6.86 166.46 166.46
Gross Sales 85.39 81.07 6.86 166.46 166.46
Total Revenue from Operations 66.16 105.11 143.60 515.14 428.81
2. Other Income 151.55 186.18 150.56 681.60 635.59
Expenses
(a) Cost of Materials consumed 38.73 47.28 220.10
(b) Changes in inventories of finished goods, work-in-progress 17.25 (5.36) 8.18 19.25 66.88
(c) Employee benefits expense 0.91 11.43 17.17 6.06 0.44
(d) Finance costs 13.91 0.02 0.02 66.38 272.90
(e) Depreciation and amortization expense 54.54 54.54 68.22 0.44 14.25
(f) Power & fuel etc. 1.14 4.46 2.33 272.90 463.30
(g) Other expenses 177.15 49.30 37.24 250.70 250.70
Total Expenses 303.30 165.67 133.40 630.29 1,057.41
3. Profit/(loss) before exceptional items and tax (1-2) (151.75) 20.50 17.40 51.31 (421.54)
4. Exceptional Items 51.31 51.31
5. Profit/(loss) before tax (3+4) (151.75) 20.50 17.40 102.62 (370.23)
6. Tax Expense
– Current Tax (14.37) 1.11 17.75 (103.15)
– Deferred Tax (137.37) 16.30 33.57 (90.69)
7. Net Profit/(Loss) related to earlier year (0.13) (1.75)
8. Other Comprehensive Income
A (i) Items that will not be reclassified to profit or loss
A (ii) Income tax relating to items that will not be reclassified to profit or loss
B (i) Items that will be reclassified to profit & loss
B (ii) Income tax relating to items that will be reclassified to profit or loss
9. Total comprehensive income (after tax) (137.47) 15.00 33.47 2,325.45 2,325.45
10. Paid up equity share capital (FV Rs. 10 each) 2,325.45 2,325.45 2,325.45 2,325.45 2,325.45
11. Other Equity (909.46) (909.46)
12. Basic / Diluted Earnings/(Loss) Per Share (Rs.)
– Basic 0.08 0.06 0.14 (0.39) (0.39)
– Diluted 0.08 0.06 0.14 (0.39) (0.39)
S No. Particulars As at 31.03.2026 (AUDITED) As at 31.03.2025 (AUDITED)
A) 1 ASSETS
Non-Current assets
(a) Property Plant & Equipment 3,122.17 3,334.03
(b) Capital Work in Progress 5,635.07 4,335.99
(c) Biological Assets 42.42 61.43
(d) Financial assets
(i) Investments 0.02 0.02
(ii) Other financial assets 65.66 65.66
(e) Deferred Tax assets (net) 295.57 313.28
(f) Other non current assets 21.45 29.45
Total non-current assets 9,182.37 8,131.87
2 Current assets
(a) Inventories 1,974.52 358.36
(b) Financial assets
(i) Trade receivables 310.79 304.34
(ii) Cash & Cash Equivalents 65.33 55.38
(iii) Other financial assets 11.59 11.65
(c) Current Tax assets(net) 1.54 1.18
(d) Other current assets 393.62 641.36
Total current assets 2,757.39 1,372.27
Total Assets 11,939.76 9,504.14
B) 1 EQUITY AND LIABILITIES
Equity
(a) Equity Share Capital 2,325.45 2,325.45
(b) Other Equity (909.46) (1,197.79)
Equity attributable to shareholder 1,416.00 1,127.66
2 Non current Liabilities
(a) Financial liabilities
(i) Borrowings 2,596.52 2,070.94
(b) Provisions 4.24 4.06
Total non-current liabilities 2,600.75 2,075.01
3 Current Liabilities
(a) Financial liabilities
(i) Borrowings 240.00 240.00
(ii) Trade Payables
– total outstanding dues of micro enterprises and small enterprises 5.28 6.59
– total outstanding dues of creditors other than micro enterprises and small enterprises 5,597.08 4,411.72
(iii) Other financial liabilities 304.59 285.42
(b) Provisions 3.78 5.05
(c) Other current Liabilities 1,772.27 1,352.71
Total current liabilities 7,923.01 6,301.47
TOTAL EQUITY AND LIABILITIES 11,939.76 9,504.14
Particulars Year Ended 31.03.2026 Audited Year Ended 31.03.2025 Audited
Cash Flow From Operating Activities:
Profit After Tax 33.47 (90.69)
Adjustments To Reconcile Profit Before Tax To Net Cash Provided By Operating Activities:
Income Tax Expenses Charged In Profit And Loss A/C 17.71 (103.61)
Depreciation And Amortization 218.16 272.90
Finance Costs 0.44 0.38
Loss/(Profit) On Sale Of Fixed Assets (227.69)
Interest Income Received (9.51) (4.01)
Increase in Equity Investment due to increase in fair value 0.00 (0.01)
Increase in Equity from issue of Cumulative Non Convertible Redeemable Preference Shares 254.86
Operating Profit Before Working Capital Changes 515.13 (152.72)
Changes In Operating Assets And Liabilities:
Trade Receivables (6.46) 3.75
Other Receivables 247.45 1.20
Inventory (1,616.16) 25.36
Provisions (1.09) 1.10
Trade And Other Payables 1,622.79 2,114.15
Biological Assets
Cash Generated From Operations 761.67 1,993.24
Income Tax (Net)
Net Cash Flow From Operating Activities (A) 761.67 1,993.24
Cash Flow From Investing Activities:
Net Sale /(Purchase) Of Fixed Assets (1,305.38) (2,568.77)
Biological Assets 19.01 (23.78)
Interest Income Received 9.51 4.01
Net Cash Flow From Investing Activities (B) (1,276.86) (2,588.54)
Cash Flow From Financing Activities:
Proceeds From Long-Term Borrowings 525.57 612.37
Finance Cost (0.44) (0.38)
Net Cash Flow From Financing Activities (C) 525.14 611.99
Net Increase In Cash And Cash Equivalents (A+B+C) 9.95 16.68
Opening Cash And Cash Equivalents 55.38 38.70
Closing Cash And Cash Equivalents 65.33 55.38